Levetiracetam Injection
Product Images NDC 66298-0467

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 66298-0467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hp Halden Pharma As, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle6 (Bottle6)

Levetiracetam 15 mg/mL intravenous injection in 0.54% sodium chloride, 100 mL single-dose dual port bag. The label details usage instructions, composition including sodium chloride and glacial acetic acid, storage conditions, and manufacturer information for Fresenius Kabi, made in Norway.*

FDA Label Image

Bottle7 (Bottle7)

Levetiracetam 15 mg/mL in 0.54% Sodium Chloride Injection, 1,500 mg in 100 mL, in single-dose bags. The label indicates a package of 24 x 100 mL bags for intravenous infusion. Manufactured for Fresenius Kabi, Lake Zurich, IL, made in Norway. Storage instructions and caution about bag leaks are included.*

FDA Label Image

Bottle8 (Bottle8)

Levetiracetam 15 mg/mL injection in 0.54% sodium chloride for intravenous infusion. The label specifies a total amount of 1,500 mg in 100 mL. It includes instruction for intravenous use only and indicates prescription-only status. A QR code is also visible on the label.*

FDA Label Image

Label (Label)

Data table presenting the frequency percentages of various adverse reactions reported for Levetiracetam injection (N=769) and Placebo (N=439) groups. The table lists adverse reactions such as asthenia, somnolence, headache, infection, and others, with their corresponding incidence rates for each group.*

FDA Label Image

Label03 (Label03)

A bar chart depicting the percentage of patients for three groups: Placebo (6.3%, N=111), Levetiracetam 1,000 mg/day (20.8%, N=106), and Levetiracetam 2,000 mg/day (35.2%, N=105). The chart shows statistically significant differences versus placebo for the Levetiracetam groups, indicated by asterisks.*

FDA Label Image

Label04 (Label04)

A bar graph comparing the percentage of patients between placebo and Levetiracetam 3,000 mg/day groups. The Y-axis represents the percentage of patients, with the placebo group at 14.4% (N=104) and the Levetiracetam group at 39.4% (N=180). A note indicates statistical significance versus placebo.*

FDA Label Image

Label05 (Label05)

A bar graph comparing the percentage of patients between placebo and Levetiracetam groups. The placebo group (N=84) shows 45.2%, while the Levetiracetam group (N=79) shows 72.2%, with a note indicating statistical significance versus placebo.*

FDA Label Image

Label06 (Label06)

FDA Label Image

Label2 (Label2)

A bar chart showing percentage of patients for placebo and two Levetiracetam dosage groups. The x-axis labels are Placebo (N=95), Levetiracetam 1,000 mg/day (N=97), and Levetiracetam 3,000 mg/day (N=101). The y-axis represents percentage of patients from 0% to 45%. The placebo group shows 7.4%, Levetiracetam 1,000 mg/day group shows 37.1%, and Levetiracetam 3,000 mg/day group shows 39.6%. An asterisk indicates statistical significance versus placebo for both Levetiracetam groups.*

FDA Label Image

Chemical Structure (Levetiracetam 01)

Chemical structure of levetiracetam, a human prescription drug active ingredient. The structure shows a 2-oxo-1-pyrrolidineacetamide molecule with an ethyl group (CH3CH2), a nitrogen atom in the ring, and an amide functional group (CONH2).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.